Cargando…

Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis

Cellular senescence and biliary fibrosis are prototypical features of obliterative cholangiopathies, such as primary sclerosing cholangitis (PSC). Telomere dysfunction can lead to senescence either through telomere erosion or damaged telomeres. Our goal was to investigate a mechanistic relationship...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jalan-Sakrikar, Nidhi, Anwar, Abid, Yaqoob, Usman, Gan, Can, Lagnado, Anthony B., Wixom, Alexander Q., Jurk, Diana, Huebert, Robert C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619490/ https://www.ncbi.nlm.nih.gov/pubmed/37707950 http://dx.doi.org/10.1172/jci.insight.170320

Ejemplares similares

Development and Characterization of Cholangioids from Normal and Diseased Human Cholangiocytes as an In Vitro Model to Study Primary Sclerosing Cholangitis
por: Loarca, Lorena, et al.
Publicado: (2017)

Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis
por: Cazzagon, Nora, et al.
Publicado: (2021)

Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation
por: Jalan‐Sakrikar, Nidhi, et al.
Publicado: (2021)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion
por: Jalan-Sakrikar, Nidhi, et al.
Publicado: (2016)

Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis
por: Tabibian, James H., et al.
Publicado: (2014)

Development and Characterization of Human Induced Pluripotent Stem Cell-Derived Cholangiocytes
por: De Assuncao, Thiago M., et al.
Publicado: (2015)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
por: Huang, Yu, et al.
Publicado: (2022)

Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis
por: Li, Xi, et al.
Publicado: (2023)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2(−/−) mouse model of primary sclerosing cholangitis (PSC)
por: Zhou, Tianhao, et al.
Publicado: (2019)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Diagnosing Biliary Strictures: Distinguishing IgG4-Related Sclerosing Cholangitis From Cholangiocarcinoma and Primary Sclerosing Cholangitis
por: Hori, Yasuki, et al.
Publicado: (2021)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes
por: Mayer, Christian, et al.
Publicado: (2020)

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation
por: Etherington, Rachel E., et al.
Publicado: (2019)

Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
por: Sclair, Seth N, et al.
Publicado: (2015)

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis
por: Gauss, Annika, et al.
Publicado: (2016)

Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
por: Fung, Brian M., et al.
Publicado: (2019)

The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2021)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

A Systematic Review of Patient‐Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Kim, Hannah P., et al.
Publicado: (2020)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
por: Dyson, Jessica Katharine, et al.
Publicado: (2020)

Abnormal Expression of ERα in Cholangiocytes of Patients With Primary Biliary Cholangitis Mediated Intrahepatic Bile Duct Inflammation
por: Cao, Hui, et al.
Publicado: (2019)

Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis
por: Yin, Chunyue
Publicado: (2023)

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
por: Greenman, Raanan, et al.
Publicado: (2023)

Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis
por: Mindikoglu, Ayse L, et al.
Publicado: (2019)

Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
por: Smith, Helen T., et al.
Publicado: (2023)

Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk
por: Nanjundappa, Roopa H., et al.
Publicado: (2023)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids
por: Garcia Moreno, Ana Sofia, et al.
Publicado: (2023)

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis
por: Borchers, Andrea T., et al.
Publicado: (2009)

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
por: Rupp, Christian, et al.
Publicado: (2014)

Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review
por: Mago, Sheena, et al.
Publicado: (2020)

Management of biliary stricture in patients with IgG4-related sclerosing cholangitis
por: Miyazawa, Masaki, et al.
Publicado: (2020)

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma
por: Miyabe, Katsuyuki, et al.
Publicado: (2022)

SECONDARY SCLEROSING CHOLANGITIS WITH BILIARY CAST DUE TO SARS-COV-2 INFECTION
por: Kagihara, Jaclyn E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sbs5hh8i90emqi4be2hbpj4tvq